Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media
- PMID: 1997946
Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media
Abstract
Expression of the human protooncogene c-myc is necessary for replication, and may be inhibited in a sequence-specific, dose-dependent manner by an antisense oligodeoxynucleotide specific for the first five codons of c-myc mRNA. Antisense inhibition of c-myc inhibits the proliferation and enhances the differentiation of the HL-60 human promyelocytic leukemia cell line. In order to raise the efficacy of antisense oligomers, HL-60 cells were grown in a serum-free medium so as to minimize nuclease activity in the culture medium. Daily addition of anti-c-myc oligomer was then found to induce terminal granulocytic differentiation of 80% or more of HL-60 cells, and inhibit colony formation by greater than 50%, comparable to 1% Me2SO.
Similar articles
-
Anti-c-myc DNA increases differentiation and decreases colony formation by HL-60 cells.In Vitro Cell Dev Biol. 1989 Mar;25(3 Pt 1):297-302. doi: 10.1007/BF02628470. In Vitro Cell Dev Biol. 1989. PMID: 2647708
-
The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.Oncogene. 1990 Jun;5(6):873-7. Oncogene. 1990. PMID: 2141686
-
Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.Cancer Res. 1989 Oct 1;49(19):5329-33. Cancer Res. 1989. PMID: 2670202
-
Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes.Immunobiology. 1992 Aug;185(2-4):150-8. doi: 10.1016/S0171-2985(11)80637-6. Immunobiology. 1992. PMID: 1452198 Review.
-
[Serum-free culture for leukemia cells].Hum Cell. 1993 Mar;6(1):49-56. Hum Cell. 1993. PMID: 8343448 Review. Japanese.
Cited by
-
Myc roles in hematopoiesis and leukemia.Genes Cancer. 2010 Jun;1(6):605-16. doi: 10.1177/1947601910377495. Genes Cancer. 2010. PMID: 21779460 Free PMC article.
-
Elastin-derived peptides (EDPs) as a potential pro-malignancy factor in human leukemia cell lines.Immunol Res. 2024 Oct;72(5):1092-1107. doi: 10.1007/s12026-024-09511-7. Epub 2024 Jul 5. Immunol Res. 2024. PMID: 38967692 Free PMC article.
-
Oligonucleotide treatment of ras-induced tumors in nude mice.Mol Biotechnol. 2001 May;18(1):35-55. doi: 10.1385/MB:18:1:35. Mol Biotechnol. 2001. PMID: 11439698 Review.
-
Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.Mol Med. 1995 Sep;1(6):647-58. Mol Med. 1995. PMID: 8529131 Free PMC article.
-
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers.Onco Targets Ther. 2023 Jun 7;16:371-383. doi: 10.2147/OTT.S366627. eCollection 2023. Onco Targets Ther. 2023. PMID: 37309471 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources